94 related articles for article (PubMed ID: 15019547)
21. Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?
Frand J; Borislavsky A; Boaz M; Matas Z; Shargorodsky M
Atherosclerosis; 2013 Jan; 226(1):146-8. PubMed ID: 23177015
[TBL] [Abstract][Full Text] [Related]
22. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
23. Role of haptoglobin phenotype in end-stage kidney disease.
Burbea Z; Nakhoul F; Rosenberg S; Zoabi R; Skorecki K; Hochberg I; Miller-Lotan R; Benchetrit S; Weissgarten J; Knecht A; Tovbin D; Levy NS; Levy AP
Nephron Exp Nephrol; 2004; 97(2):e71-6. PubMed ID: 15218325
[TBL] [Abstract][Full Text] [Related]
24. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Cheung N; Wang JJ; Klein R; Couper DJ; Sharrett AR; Wong TY
Diabetes Care; 2007 Jul; 30(7):1742-6. PubMed ID: 17389333
[TBL] [Abstract][Full Text] [Related]
25. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
Liu J; Yuen J; Kang S
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
[TBL] [Abstract][Full Text] [Related]
26. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery.
Delanghe J; Cambier B; Langlois M; De Buyzere M; Neels H; De Bacquer D; Van Cauwelaert P
Atherosclerosis; 1997 Jul; 132(2):215-9. PubMed ID: 9242967
[TBL] [Abstract][Full Text] [Related]
27. Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans.
Park KU; Song J; Kim JQ
J Clin Pathol; 2004 Oct; 57(10):1094-5. PubMed ID: 15452167
[TBL] [Abstract][Full Text] [Related]
28. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
[TBL] [Abstract][Full Text] [Related]
29. Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
Van Vlierberghe H; Delanghe JR; De Bie S; Praet M; De Paepe A; Messiaen L; De Vos M; Leroux-Roels G
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1077-81. PubMed ID: 11564959
[TBL] [Abstract][Full Text] [Related]
30. Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study.
Idris I; Deepa R; Fernando DJ; Mohan V
Diabetes Res Clin Pract; 2008 Aug; 81(2):243-9. PubMed ID: 18495288
[TBL] [Abstract][Full Text] [Related]
31. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.
Suleiman M; Aronson D; Asleh R; Kapeliovich MR; Roguin A; Meisel SR; Shochat M; Sulieman A; Reisner SA; Markiewicz W; Hammerman H; Lotan R; Levy NS; Levy AP
Diabetes; 2005 Sep; 54(9):2802-6. PubMed ID: 16123372
[TBL] [Abstract][Full Text] [Related]
32. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S
Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease.
Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL
Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690
[TBL] [Abstract][Full Text] [Related]
34. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
35. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese.
Na N; Delanghe JR; Taes YE; Torck M; Baeyens WR; Ouyang J
Clin Chim Acta; 2006 Mar; 365(1-2):319-24. PubMed ID: 16256097
[TBL] [Abstract][Full Text] [Related]
36. Haptoglobin phenotype and diabetic nephropathy.
Nakhoul FM; Zoabi R; Kanter Y; Zoabi M; Skorecki K; Hochberg I; Leibu R; Miller B; Levy AP
Diabetologia; 2001 May; 44(5):602-4. PubMed ID: 11380078
[TBL] [Abstract][Full Text] [Related]
37. Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients.
Dahan I; Farber E; Thauho N; Nakhoul N; Francis A; Awawde M; Levy AP; Kim-Shapiro DB; Basu S; Nakhoul F
J Diabetes Res; 2015; 2015():613860. PubMed ID: 26171400
[TBL] [Abstract][Full Text] [Related]
38. Haptoglobin polymorphism and complications in established essential arterial hypertension.
Delanghe JR; Duprez DA; De Buyzere ML; Bergez BM; Callens BY; Leroux-Roels GG; Clement DL
J Hypertens; 1993 Aug; 11(8):861-7. PubMed ID: 8228210
[TBL] [Abstract][Full Text] [Related]
39. Haptoglobin polymorphism in Korean patients with cardiovascular diseases.
Hong SH; Kang BY; Lim JH; Namkoong Y; Oh MY; Kim JQ; Lee CC
Hum Hered; 1997; 47(5):283-7. PubMed ID: 9358017
[TBL] [Abstract][Full Text] [Related]
40. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
